Position in GILD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,491,297
+$2,223,707 QoQ
Shares Held
19,719
+927.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.73%
of 13F equity value
Holder Rank
#766
of 2,266 holders
Holding Since
Mar 2020
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Northwest Bancshares, Inc. holds $21,127,120 across 8 Drug Manufacturers - General names. GILD ranks #4 (11.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
53,406 | $6,862,671 | |
| 2 | SNY |
Sanofi
|
94,207 | $4,018,870 | |
| 3 | LLY |
ELI LILLY & Co
|
2,573 | $3,086,133 | |
| 4 | GILD |
Gilead Sciences, Inc.
This page
|
19,719 | $2,491,297 | |
| 5 | JNJ |
Johnson & Johnson
|
9,353 | $2,375,381 | |
| 6 | ABBV |
AbbVie Inc.
|
5,470 | $1,376,469 | |
| 7 | PFE |
Pfizer Inc
|
24,413 | $587,865 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
5,700 | $328,434 |
All Filings in GILD
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,491,297 | 19,719 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $267,590 | 1,920 | Shares | Other | 2026-05-12 | |
| 2025-12-31 | $235,660 | 1,920 | Shares | Other | 2026-02-13 | |
| 2025-06-30 | $202,004 | 1,822 | Shares | Other | 2025-08-07 | |
| 2025-03-31 | $204,154 | 1,822 | Shares | Other | 2025-05-07 | |
| 2020-03-31 | $3,919,292 | 52,425 | Shares | Other | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||